Whittier Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.4M Buy
57,283
+1,377
+2% +$80.3K 0.04% 217
2025
Q4
$3.04M Sell
55,906
-6,650
-11% -$320K 0.03% 233
2025
Q3
$2.84M Sell
62,556
-3,464
-5% -$162K 0.03% 235
2025
Q2
$3.06M Sell
66,020
-5,251
-7% -$258K 0.04% 248
2025
Q1
$4.35M Sell
71,271
-3,555
-5% -$207K 0.06% 212
2024
Q4
$4.23M Sell
74,826
-189
-0.3% -$10.6K 0.06% 213
2024
Q3
$3.88M Sell
75,015
-6,329
-8% -$297K 0.05% 228
2024
Q2
$3.38M Sell
81,344
-7,253
-8% -$325K 0.05% 229
2024
Q1
$4.8M Buy
88,597
+19,382
+28% +$987K 0.07% 200
2023
Q4
$3.55M Sell
69,215
-39,001
-36% -$2.05M 0.06% 227
2023
Q3
$6.28M Sell
108,216
-550
-0.5% -$33.7K 0.11% 168
2023
Q2
$6.96M Sell
108,766
-2,557
-2% -$171K 0.12% 154
2023
Q1
$7.72M Buy
111,323
+1,392
+1% +$98.2K 0.14% 145
2022
Q4
$7.91M Sell
109,931
-1,355
-1% -$102K 0.15% 140
2022
Q3
$7.91M Buy
111,286
+981
+0.9% +$71.2K 0.17% 136
2022
Q2
$8.49M Sell
110,305
-1,417
-1% -$108K 0.17% 134
2022
Q1
$8.16M Sell
111,722
-1,862
-2% -$125K 0.14% 146
2021
Q4
$7.08M Sell
113,584
-1,135
-1% -$66.6K 0.12% 162
2021
Q3
$6.79M Sell
114,719
-5,146
-4% -$339K 0.12% 156
2021
Q2
$8.01M Buy
119,865
+354
+0.3% +$23.1K 0.14% 146
2021
Q1
$7.54M Sell
119,511
-128,653
-52% -$8M 0.15% 140
2020
Q4
$15.4M Buy
248,164
+113,410
+84% +$6.97M 0.33% 77
2020
Q3
$8.12M Buy
134,754
+11,062
+9% +$666K 0.19% 117
2020
Q2
$7.27M Sell
123,692
-24,854
-17% -$1.49M 0.2% 121
2020
Q1
$8.28M Sell
148,546
-15,479
-9% -$946K 0.27% 88
2019
Q4
$10.5M Buy
164,025
+55,226
+51% +$3.16M 0.28% 90
2019
Q3
$5.52M Buy
108,799
+8,839
+9% +$415K 0.16% 141
2019
Q2
$4.53M Buy
99,960
+3,503
+4% +$163K 0.13% 155
2019
Q1
$4.6M Sell
96,457
-59,633
-38% -$2.97M 0.14% 150
2018
Q4
$8.11M Sell
156,090
-41,172
-21% -$2.21M 0.28% 95
2018
Q3
$12.2M Buy
197,262
+29,064
+17% +$1.72M 0.38% 72
2018
Q2
$9.31M Sell
168,198
-7,520
-4% -$406K 0.31% 94
2018
Q1
$11.1M Buy
175,718
+116
+0.1% +$7.46K 0.37% 78
2017
Q4
$10.8M Sell
175,602
-2,331
-1% -$146K 0.38% 80
2017
Q3
$11.3M Buy
177,933
+47,459
+36% +$2.77M 0.41% 71
2017
Q2
$7.27M Sell
130,474
-2,601
-2% -$142K 0.28% 104
2017
Q1
$7.24M Buy
133,075
+5,100
+4% +$280K 0.29% 98
2016
Q4
$7.48M Sell
127,975
-9,822
-7% -$537K 0.32% 88
2016
Q3
$7.43M Sell
137,797
-1,516
-1% -$97.4K 0.32% 93
2016
Q2
$10.2M Sell
139,313
-630
-0.5% -$44.5K 0.45% 60
2016
Q1
$8.94M Sell
139,943
-2,430
-2% -$153K 0.4% 69
2015
Q4
$9.79M Sell
142,373
-2,670
-2% -$176K 0.44% 62
2015
Q3
$8.59M Sell
145,043
-3,870
-3% -$246K 0.42% 66
2015
Q2
$9.91M Buy
148,913
+1,336
+0.9% +$88K 0.44% 62
2015
Q1
$9.52M Buy
147,577
+7,708
+6% +$483K 0.44% 63
2014
Q4
$8.26M Buy
139,869
+96
+0.1% +$5.41K 0.39% 74
2014
Q3
$7.15M Buy
139,773
+526
+0.4% +$26.3K 0.35% 77
2014
Q2
$6.75M Sell
139,247
-7,447
-5% -$367K 0.33% 84
2014
Q1
$7.62M Hold
146,694
0.39% 72
2013
Q4
$7.8M Sell
146,694
-2,230
-1% -$114K 0.4% 72
2013
Q3
$6.89M Sell
148,924
-3,940
-3% -$173K 0.37% 79
2013
Q2
$6.83M Buy
+152,864
New +$6.64M 0.38% 75

Other funds holding BMY

Whittier Trust's BMY Position: Q1 2026 in Review

Whittier Trust increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2026, buying an estimated $80.3K and bringing the position to 57,283 shares worth $3.4M. The position accounts for 0.04% of the portfolio, ranked #217.

Whittier Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.4M in Q4 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Whittier Trust held 57,283 shares of Bristol-Myers Squibb worth $3.4M as of Q1 2026.
  • Whittier Trust bought 1,377 Bristol-Myers Squibb shares in Q1 2026, an estimated $80.3K.
  • Bristol-Myers Squibb made up 0.04% of Whittier Trust's portfolio in Q1 2026, its #217 holding.
  • Whittier Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Whittier Trust's Bristol-Myers Squibb position peaked at $15.4M in Q4 2020.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.